WallStSmart
BIOR

Biora Therapeutics Inc

NASDAQ: BIOR · HEALTHCARE · BIOTECHNOLOGY

$0.22
+0.00% today

Updated 2026-06-02

Market cap
$994990.00
P/E ratio
0.61
P/S ratio
0.74x
EPS (TTM)
$0.36
Dividend yield
52W range
$0 – $0
Volume

Biora Therapeutics Inc (BIOR) Financial statements

SEC filings — annual and quarterly data.

Balance sheet — annual

Item201820192020202120222023
Total assets$116.40M$101.73M$154.44M$108.84M$53.52M$31.21M
Cash & equivalents$49.01M$33.04M$92.08M$88.40M$30.49M$15.21M
Current assets$88.95M$74.65M$126.34M$98.43M$38.12M$19.07M
Total liabilities$153.37M$185.60M$261.43M$193.81M$155.81M$132.64M
Current liabilities$78.06M$100.34M$72.67M$61.61M$23.30M$62.97M
Long-term debt$70.61M$72.05M$161.68M$126.39M$127.81M$43.74M
Shareholder equity$-36.97M$-83.87M$-106.99M$-84.98M$-102.29M$-101.42M
Retained earnings$-142.47M$-348.48M$-541.27M$-788.69M$-826.84M$-950.96M
Accounts receivable$8.15M$22.82M$6.63M$653000.00$828000.00$830000.00
Inventory$7.62M$10.94M$12.22M$2.15M$2.60M
Goodwill$6.22M$6.22M$6.22M$6.07M$6.07M$6.07M

Frequently asked questions

What is Biora Therapeutics Inc's revenue?

Biora Therapeutics Inc's trailing twelve-month revenue is $860000.00. Revenue is the top line the whole model builds on, and at this scale the question shifts from how fast it grows to whether margins hold as it compounds.

How profitable is BIOR?

In its most recent fiscal year, BIOR ran a gross margin of 100.00%, an operating margin of -1,678,575.00%, and a net margin of -3,102,875.00%. Margins this high mean most of each extra dollar of revenue drops through to profit, which is the signature of real pricing power.

How much free cash flow does BIOR generate?

BIOR produced $-48.60M in free cash flow in its most recent fiscal year. Free cash flow is what is left after running and reinvesting in the business, and it is the cash that actually funds buybacks, dividends, and a stronger balance sheet.

Is BIOR's balance sheet healthy?

BIOR holds $15.21M in cash and equivalents against $43.74M in long-term debt, on $-101.42M of shareholder equity. That debt is best read against the cash flow the business throws off each year.